All stock lists
Nordicus Partners Corporation Common Stock (OTC:NORD)
US · Delayed Price · Currency is USD
Industrials · Consulting Services
Nasdaq CM since Oct 2026
3.50-1.25 (-26.32%)
Market cap
$68.1M
Insider Score
Health Score
Listed since
Jun 12, 1996
Website
Insider Score
––Not scored
NORD Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Weak
From NORD’s reported statements · Q2 2026 (trailing 12 months) · 4 of 5 pillars
Profitability—
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$5.1M
- Net margin
- —
Leverage20 / 20
Little or no net debt.
- Total debt
- $82K
- Cash
- $6K
- Debt / equity
- 0.00
Liquidity0 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $298K
- Current liabilities
- $1.7M
- Current ratio
- 0.18
Cash generation3 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$4.2M
- Free cash flow
- -$4.3M
Dilution & runway0 / 20
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 19.2M
- Share growth (1y)
- 10.9%
- Cash runway
- 0 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
NORD Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | -100.00 % | -100.00 % | — | -100.00 % |
| Cost of Revenue | 1.30 K | 1.55 K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -1.30 K | -1.55 K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 266.38 K | 480.99 K | 538.69 K | 468.22 K | 342.88 K | 233.43 K |
| R&D Expense | 437.88 K | 283.16 K | 445.46 K | 454.70 K | 423.65 K | 568.42 K |
| Operating Expenses | 819.62 K | 1.21 M | 1.12 M | 1.21 M | 831.89 K | 888.49 K |
| Operating Income | -819.62 K | -1.21 M | -1.12 M | -1.21 M | -831.89 K | -888.49 K |
| Pretax Income | -2.31 M | -80.92 K | -1.25 M | -1.51 M | -1.21 M | -606.40 K |
| Tax Provision | 0.00 | 0.00 | -20.31 K | 0.00 | 0.00 | 0.00 |
| Net Income | -2.28 M | -56.11 K | -1.23 M | -1.51 M | -1.21 M | -606.40 K |
| EPS (Basic) | -0.12 | -0.00 | -0.07 | -0.08 | -0.07 | -0.07 |
| EPS (Diluted) | -0.12 | -0.00 | -0.07 | -0.08 | -0.07 | -0.08 |
| Shares Outstanding | 19.17 M | 18.12 M | 18.61 M | 17.88 M | 17.29 M | 9.21 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.